Brief: Solvonis Therapeutics Says NIDA To Fund Early Preclinical Evaluation Of Svn-015

Solvonis Therapeutics

03/12/2025 07:24

Dec 3 (Reuters) - Solvonis Therapeutics PLC SVNS.L:

NIDA TO FUND EARLY PRECLINICAL EVALUATION OF SVN-015

 ((Reuters.Briefs@thomsonreuters.com;;))